Acute Coronary Syndrome - 863 Studies Found Recruiting : A Web-Based Tailored Nursing Intervention to Increase Walking in Patients After an Acute Coronary Syndrome : Acute Coronary Syndrome : 2015-11-23 : Behavioral: TAVIEenM@RCHE The Terminated : A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients : Acute Coronary Syndrome : 2009-02-26 : Drug: Apixaban Apixaban 2.5 mg Completed : LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes : Acute Coronary Syndromes : 2005-09-21 : Drug: rosuvastatin calcium Oth Completed : Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome : Acute Coronary Syndrome : 2011-06-27 : Drug: GIK solution Patients receive 0.3 ml/kg/hr GIK solution or the same volume of normal saline depend Completed : Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome : Acute Coronary Syndrome : 2010-03-15 : Drug: ADP receptor inhibitors Dosage regimen as determined by the treating physician. Completed : Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome : Acute Coronary Syndrome : 2012-03-16 : Drug: Clopidogrel 600mg loadin Completed : Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome : Acute Coronary Syndrome : 2007-08-08 : Drug: Iodofiltic acid I 123 Completed : LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients : Acute Coronary Syndrome : 2014-02-27 : Drug: Rosuvastatin Rosuvastatin 20 mg/d compared to 10 mg/day Active, not recruiting : Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes : Acute Coronary Syndrome : 2014-12-15 : Drug: ticagrelor Drug: clopidogrel Active, not recruiting : ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab : Acute Coronary Syndrome : 2012-08-08 : Drug: alirocumab <<< Previous | Next >>>
